THERALASE TECHNOLOGIES INC (TLT.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:TLT - CA88337V1004 - Common Stock
TLT.CA Key Statistics, Chart & Performance
The current stock price of TLT.CA is 0.25 CAD. In the past month the price increased by 56.25%. In the past year, price decreased by -9.09%.
TLT.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to TLT.CA. When comparing the yearly performance of all stocks, TLT.CA turns out to be only a medium performer in the overall market: it outperformed 40.98% of all stocks.
TLT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TLT.CA. TLT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
TLT.CA Financial Highlights
Over the last trailing twelve months TLT.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 23.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -144.9% | ||
| ROE | -398.4% | ||
| Debt/Equity | 0.19 |
TLT.CA Forecast & Estimates
9 analysts have analysed TLT.CA and the average price target is 0.71 CAD. This implies a price increase of 185.6% is expected in the next year compared to the current price of 0.25.
For the next year, analysts expect an EPS growth of 39.41% and a revenue growth 13.84% for TLT.CA
TLT.CA Ownership
About TLT.CA
Company Profile
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. The company is headquartered in Toronto, Ontario. The company went IPO on 2004-11-02. The firm is engaged in the research and development of light, radiation, sound and drug-activated small molecule compounds and their associated formulations, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses, with minimal impact on surrounding healthy tissue. The company operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which researches, develops, manufactures and distributes cool laser therapy systems to healthcare practitioners, predominantly for the healing of pain.
Company Info
THERALASE TECHNOLOGIES INC
41 Hollinger Road
TORONTO ONTARIO M4B 3G4 CA
CEO: Shawn Shirazi
Employees: 20
Phone: 14166995273
THERALASE TECHNOLOGIES INC / TLT.CA FAQ
What does THERALASE TECHNOLOGIES INC do?
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. The company is headquartered in Toronto, Ontario. The company went IPO on 2004-11-02. The firm is engaged in the research and development of light, radiation, sound and drug-activated small molecule compounds and their associated formulations, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses, with minimal impact on surrounding healthy tissue. The company operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which researches, develops, manufactures and distributes cool laser therapy systems to healthcare practitioners, predominantly for the healing of pain.
What is the current price of TLT stock?
The current stock price of TLT.CA is 0.25 CAD. The price increased by 2.04% in the last trading session.
Does TLT stock pay dividends?
TLT.CA does not pay a dividend.
What is the ChartMill rating of THERALASE TECHNOLOGIES INC stock?
TLT.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of THERALASE TECHNOLOGIES INC (TLT.CA)?
THERALASE TECHNOLOGIES INC (TLT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
Can you provide the market cap for THERALASE TECHNOLOGIES INC?
THERALASE TECHNOLOGIES INC (TLT.CA) has a market capitalization of 61.95M CAD. This makes TLT.CA a Micro Cap stock.